If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Trading Update

3 Feb 2015 07:00

RNS Number : 7942D
Applied Graphene Materials PLC
03 February 2015
 

 

 

3 February 2015

 

 

Applied Graphene Materials plc

 

("Applied Graphene Materials", "the Group" or "the Company")

 

Post-close trading update

 

Applied Graphene Materials plc, the producer of specialty graphene materials, is pleased to provide the following update ahead of the announcement of its interim results for the period ended 31 January 2015.

 

The overall trading performance of the Group for the period has been in line with the Directors' expectations with net cash of approximately £6.6 million at the period end. Operational priorities have been customer sampling, developing customer relationships, performance data generation and ongoing enhancements to the manufacturing and dispersion processes. The Board is pleased with the progress achieved in these areas and in particular the pace of progress since the announcement of the full year results.

 

Customer relationships and sampling

As previously reported, November 2014 was a record month for Applied Graphene Materials for the number of samples provided to customers. Approximately 90% of our ongoing engagements are with the Group's three core target markets of advanced composites, coatings and functional fluids, encompassing global operators in these markets. We have taken encouragement from early performance test data.

 

Investments in our Senior Management team

The Group recently announced two new senior management appointments, being Nigel Blatherwick as Commercial Director and Dr Adrian Potts as Vice President Business Development for North America. Both have extensive experience of business development in the specialty materials sector and will be invaluable to the Group as it extends its commercial partnerships and capitalises on its international profile. Nigel will lead the Group's commercial activities and Adrian, who is based in Oklahoma, will spearhead growth into the North American markets where considerable interest is anticipated.

 

Manufacturing and dispersion processes

During the period, the Group commenced preliminary work on the front end engineering design of a larger scale mk4 production asset and this design work will continue in the second half of the financial year. This investment is in addition to that already made in the Group's in-house engineering expertise which to date has been focused on developing our existing proprietary production equipment. Whilst the cost of this design work is modest in the context of the likely overall cost of the construction of a larger production asset, this investment signifies the Group's intention to seek to put in place capacity in advance of anticipated growth in demand to secure the Group's long term position in this exciting market opportunity.

During the period, the Group has gradually increased the run rates of its production assets as part of plans to evidence the consistency and quality of production at higher volumes. This activity will also continue in the second half of the financial year as ongoing enhancements continue to be made to the Group's manufacturing and dispersion processes.

 

Outlook

The effects of these investments in customer relationships and front end engineering design work is that some costs will be brought forwards into the second half of the current financial year and into 2016 in order to support the long term growth of the Group.

 

Our priorities for second half of the year include:

· Scaling production through demonstrating running at higher production rates;

· Sampling customers; and

· Supporting in depth, high quality customer relationships.

 

The Board remains confident that Applied Graphene Materials is well placed to play a leading role in meeting the growing global appetite for graphene.

 

Interim results

Applied Graphene Materials' interim results for the period ended 31 January 2015 are expected to be announced on Wednesday 25 March 2015.

 

Ends

 

For further information, please contact:

 

Applied Graphene Materials +44 (0) 1642 438 214

Jon Mabbitt, Chief Executive Officer

Oliver Lightowlers, Chief Financial Officer

 

N+1 Singer +44 (0) 207 496 3000

Shaun Dobson / Richard Lindley

 

Hudson Sandler +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

 

Notes to Editors

Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University. The Group was admitted to AIM in November 2013, raising £11 million, and is based at the Wilton Site on Teesside.

The Group has developed a proprietary bottom-up process for the production of high purity graphene nanoplatelets and owns the intellectual property and know-how behind this process. Applied Graphene Materials' process is based on sustainable, readily available raw materials and therefore does not rely on the supply of graphite, unlike a number of other graphene production techniques. It is capable of producing high purity graphene using a continuous process. Applied Graphene Materials provides dispersion and product integration expertise to deliver solutions for a wide range of applications.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTTTMJTMBAMBTA
Date   Source Headline
11th Jan 20163:36 pmRNSDirector/PDMR Shareholding
8th Jan 201612:13 pmRNSResult of Meeting
18th Dec 20157:00 amRNSPlacing and Open Offer
16th Nov 20157:00 amRNSFull Year Results
23rd Oct 20157:00 amRNSJoint Development Agreements and Collaborations
21st Sep 20155:19 pmRNSHolding(s) in Company
18th Sep 20157:00 amRNSPeriod end trading update
9th Jul 20157:00 amRNSIssue of share options to Directors
30th Jun 20153:36 pmRNSHolding(s) in Company
17th Jun 20157:00 amRNSFirst Patent Approval
19th May 20154:40 pmRNSSecond Price Monitoring Extn
19th May 20154:35 pmRNSPrice Monitoring Extension
14th May 20157:00 amRNSPositive results from independent oil trials
27th Apr 20159:21 amRNSHolding(s) in Company
22nd Apr 20154:44 pmRNSHolding(s) in Company
22nd Apr 20153:28 pmRNSHolding(s) in Company
21st Apr 20154:46 pmRNSHolding(s) in Company
17th Apr 20157:00 amRNSPositive results from independent coatings trials
2nd Apr 20159:46 amRNSHolding(s) in Company
1st Apr 20154:39 pmRNSHolding(s) in Company
25th Mar 20157:00 amRNSInterim Results
3rd Feb 20157:00 amRNSTrading Update
27th Jan 201511:25 amRNSIssue of equity and total voting rights
22nd Jan 20157:00 amRNSSenior Management Appointments
22nd Dec 20147:00 amRNSDirectorate Change
15th Dec 201411:36 amRNSResult of AGM
15th Dec 20147:00 amRNSAGM Statement
24th Nov 20147:00 amRNSPosting of Annual Report and Notice of AGM
17th Nov 20147:00 amRNSInvestor site visit
5th Nov 20147:00 amRNSAppointment of Non-Executive Director
5th Nov 20147:00 amRNSFull Year Results
5th Sep 20147:00 amRNSPre-close update
28th Jul 20147:00 amRNSIssue of share options to Directors
9th Jul 201410:17 amRNSGrant of Options to Directors
2nd Jul 20144:36 pmRNSHolding(s) in Company
23rd May 20143:08 pmRNSIssue of Share Options
30th Apr 20143:40 pmRNSReplacement - Holding(s) in Company
28th Apr 20148:50 amRNSHolding(s) in Company
1st Apr 20147:00 amRNSAppointment of Non Executive Director
1st Apr 20147:00 amRNSInterim Results
19th Mar 20147:00 amRNSNotice of Interim Results
18th Mar 201411:00 amRNSDirectorate Change
20th Jan 20144:39 pmRNSHolding(s) in Company
15th Jan 201410:59 amRNSIssue of Equity
27th Nov 20134:40 pmRNSSecond Price Monitoring Extn
27th Nov 20134:35 pmRNSPrice Monitoring Extension
26th Nov 20134:40 pmRNSSecond Price Monitoring Extn
26th Nov 20134:35 pmRNSPrice Monitoring Extension
22nd Nov 201312:39 pmRNSHolding(s) in Company
20th Nov 20137:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.